[18F]SPA-RQ/PET Study of NK1 receptors in the Whole Body of Guinea Pig and Rat.
Ontology highlight
ABSTRACT: There is a substantial interest in the development of NK1 substance P antagonists as potential treatments for various neuropsychiatric and somatic disorders. The aim of this study was to determine whether [18F]SPA-RQ can be utilized as a tool for studying the whole body distribution and function of NK1 receptors in preclinical settings. The compound was injected into guinea pigs with or without premedication with a NK1 receptor antagonist (NK1A-2). For comparison, we included two rats in the study, as the affinity of antagonists for NK1 receptors is known to vary between species. The whole body biodistribution of the tracer was determined at several time points. The tracer showed specific binding in organs compatible with the known location of NK1-receptors. Premedication with a
SUBMITTER: Gronroos TJ
PROVIDER: S-EPMC6938475 | biostudies-literature | 2019 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA